P26664 (POLG_HCV1) Hepatitis C virus genotype 1a (isolate 1) (HCV)
Genome polyprotein UniProtKBInterProInteractive Modelling
3011 aa; Sequence (Fasta)
Available Structures
Envelope glycoprotein E2 384-746; PRO_0000037521
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8rjj.1.B | monomer | 0.68 | 75.21 | |||
| 7t6x.1.A | monomer | 0.67 | 1×NAG; | 89.23 | ||
Protease NS2 810-1026; PRO_0000037523
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of NS3/4A protease variant R155K in complex with vaniprevir | monomer | 33.33 | 1×SU3; 2×SO4; 1×ZN; | |||
| HCV NS3/4A protease domain of genotype 1a3a chimera in complex with glecaprevir | monomer | 100 | 2×EDO; 1×ZN; 2×SO4; 1×O31; 1×CL; | |||
| HCV NS3/4A protease A156T, D168E double mutant in complex with glecaprevir | monomer | 100 | 1×ZN; 1×O31; 1×GOL; 3×SO4; | |||
| HCV NS3/4A protease domain of genotype 1a D168E in complex with glecaprevir | monomer | 100 | 1×ZN; 1×O31; 2×SO4; 1×CL; | |||
| Crystal structure of HCV NS3/4A protease in complex with JZ01-15, an analogue of 5172-mcP1P3 | monomer | 100 | 1×9H4; 1×SO4; 1×ZN; | |||
| Crystal structure of HCV NS3/4A protease in complex with AM-07, an analogue of 5172-mcP1P3 | monomer | 100 | 1×9H7; 1×SO4; 1×ZN; | |||
| HCV NS3/4A protease A156T mutant | monomer | 100 | 1×ZN; 1×GOL; 4×SO4; | |||
| HCV NS3/4A protease domain of genotype 1a C159 in complex with glecaprevir | monomer | 100 | 1×O31; 1×ZN; 2×SO4; 1×CL; | |||
| HCV NS3/4A protease domain of genotype 1a in complex with glecaprevir | monomer | 100 | 4×EDO; 2×SO4; 1×ZN; 1×O31; | |||
| HCV NS3/4A protease A156T mutant in complex with glecaprevir | monomer | 100 | 1×ZN; 1×O31; 2×GOL; 2×SO4; | |||
| HCV NS3/4A protease domain of genotype 1a3a chimera in complex with grazoprevir | monomer | 100 | 1×SUE; 1×ZN; 2×MES; 3×SO4; | |||
Serine protease/helicase NS3 1027-1657; PRO_0000037524
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of HCV NS3-4A Protease with an Inhibitor Derived from a Boronic Acid |
Heteromer | 98.89 | 1×ZN; 1×BE8; | |||
| HCV NS3-4A protease domain complexed with a macrocyclic ketoamide inhibitor, SCH419021 |
Heteromer | 98.89 | 1×ZN; 1×NHN; | |||
| Molecular mechanisms of viral and host-cell substrate recognition by HCV NS3/4A protease |
Heteromer Q8IUC6; | 90.61 | 1×SO4; 1×ZN; | |||
| Molecular mechanisms of viral and host-cell substrate recognition by HCV NS3/4A protease |
Heteromer Q7Z434; | 90.61 | 2×SO4; 1×ZN; | |||
| Hepatitis C Protease NS3-4A serine protease with Ketoamide Inhibitor SCH225724 Bound |
Heteromer Q9QP61; | 98.89 | 2×ZN; 1×UNH; | |||
| CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDIN… |
Heteromer O39914; | 98.33 | 2×ZN; 1×CPX; | |||
| Crystal structure of the designed protein DNCR2/danoprevir/NS3a complex |
Heteromer | 92.18 | 1×ZN; 1×TSV; 3×SO4; | |||
| HCV NS3 Protease Domain with ketoamide inhibitor |
Heteromer Q9WMX2; | 98.67 | 1×ZN; | |||
| Crystal structure of NS3/4A protease variant R155K in complex with vaniprevir | monomer | 33.33 | 1×SU3; 2×SO4; 1×ZN; | |||
| HCV NS3/4A protease domain of genotype 1a3a chimera in complex with glecaprevir | monomer | 100 | 2×EDO; 1×ZN; 2×SO4; 1×O31; 1×CL; | |||
| HCV NS3/4A protease A156T, D168E double mutant in complex with glecaprevir | monomer | 100 | 1×ZN; 1×O31; 1×GOL; 3×SO4; | |||
| HCV NS3/4A protease domain of genotype 1a D168E in complex with glecaprevir | monomer | 100 | 1×ZN; 1×O31; 2×SO4; 1×CL; | |||
| Crystal structure of HCV NS3/4A protease in complex with JZ01-15, an analogue of 5172-mcP1P3 | monomer | 100 | 1×9H4; 1×SO4; 1×ZN; | |||
| Crystal structure of HCV NS3/4A protease in complex with AM-07, an analogue of 5172-mcP1P3 | monomer | 100 | 1×9H7; 1×SO4; 1×ZN; | |||
| HCV NS3/4A protease A156T mutant | monomer | 100 | 1×ZN; 1×GOL; 4×SO4; | |||
| HCV NS3/4A protease domain of genotype 1a C159 in complex with glecaprevir | monomer | 100 | 1×O31; 1×ZN; 2×SO4; 1×CL; | |||
| HCV NS3/4A protease domain of genotype 1a in complex with glecaprevir | monomer | 100 | 4×EDO; 2×SO4; 1×ZN; 1×O31; | |||
| HCV NS3/4A protease A156T mutant in complex with glecaprevir | monomer | 100 | 1×ZN; 1×O31; 2×GOL; 2×SO4; | |||
| HCV NS3/4A protease domain of genotype 1a3a chimera in complex with grazoprevir | monomer | 100 | 1×SUE; 1×ZN; 2×MES; 3×SO4; | |||
| HCV NS3/4A protease A156T, D168E double mutant | monomer | 92.14 | 1×ZN; 1×BME; 3×SO4; | |||
| Crystal structure of HCV NS3/4A D168A protease in complex with JZ01-15 | monomer | 92.05 | 1×9H4; 1×ZN; 4×EDO; 2×GOL; 2×SO4; | |||
| Crystal structure of HCV NS3/4A protease in complex with NR01-145 | monomer | 92.61 | 1×ZN; 1×ZKJ; 3×EDO; 1×SO4; | |||
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-145 | monomer | 92.05 | 1×ZKJ; 1×ZN; 1×SO4; | |||
| Crystal structure of HCV NS3/4A protease in complex with NR01-127 | monomer | 92.61 | 1×ZN; 1×ZJG; 9×EDO; 1×SO4; | |||
| Crystal structure of HCV NS3/4A D168A protease in complex with JZ01-19 | monomer | 92.05 | 5×EDO; 1×ZN; 1×ZJP; 1×SO4; | |||
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-149 | monomer | 92.05 | 1×ZN; 1×ZJJ; 11×EDO; 1×SO4; | |||
| Crystal structure of HCV NS3/4A protease in complex with NR01-115 | monomer | 92.61 | 1×ZN; 11×EDO; 1×ZKA; 1×SO4; | |||
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-127 | monomer | 91.48 | 1×ZJG; 4×EDO; 1×ZN; 3×SO4; | |||
| Crystal structure of HCV NS3/4A protease in complex with NR01-149 | monomer | 92.61 | 1×ZN; 1×ZJJ; 1×EDO; 1×SO4; | |||
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-115 | monomer | 91.95 | 1×ZN; 1×ZKA; 10×EDO; 2×SO4; | |||
Non-structural protein 4A 1658-1711; PRO_0000037525
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of HCV NS3-4A Protease with an Inhibitor Derived from a Boronic Acid |
Heteromer | 98.89 | 1×ZN; 1×BE8; | |||
| HCV NS3-4A protease domain complexed with a macrocyclic ketoamide inhibitor, SCH419021 |
Heteromer | 98.89 | 1×ZN; 1×NHN; | |||
| Crystal structure of NS3/4A protease variant R155K in complex with vaniprevir | monomer | 33.33 | 1×SU3; 2×SO4; 1×ZN; | |||
RNA-directed RNA polymerase 2421-3011; PRO_0000037528
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| HCV NS5B genotype 1a in complex with 1,5 benzodiazepine inhibitor 6 | monomer | 98.4 | 1×IX6; 7×SO4; 3×GOL; | |||
| Crystal structure of the hepatitis C virus NS5B RNA-dependent RNA polymerase genotype 1a complex wi… | monomer | 98.93 | 1×33F; 14×GOL; | |||
| HCV NS5B 1A Y316 bound to Compound 49 | monomer | 98.22 | 3×SO4; 1×K4P; | |||
| Crystal structure of the hepatitis C virus NS5B RNA-dependent RNA polymerase genotype 1a complex wi… | monomer | 98.93 | 1×63F; 5×PO4; | |||
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2xi2.1.A | monomer | 0.83 | 98.77 | |||